Brief: Lee's Pharmaceutical Says Unit Obtained Imported Drug License For Unidrox From China's NMPA
26/06/2020 01:13
June 26 (Reuters) - Lee's Pharmaceutical Holdings Ltd
0950.HK :
* ON 12 JUNE, UNIT OBTAINED IMPORTED DRUG LICENSE FOR
UNIDROX FROM
CHINA'S NMPA
Source text https://bit.ly/3g5cxhf
Further company coverage: 0950.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lees Pharmaceutical Holdings
See all newsBrief: Lee's Pharmaceutical Announces Share Repurchase Program Under Repurchase Mandate
Brief: Lee's Pharmaceutical To Receive Funding From Gates Foundation For Synthetic Surfactant Project
Brief: Lee's Pharmaceutical Says Zhaoke Hefei To Contribute Rmb25 Million To Partnership Fund
Brief: Lee's Pharmaceutical Declares Final Dividend Of HK2.3 Cents Per Share
Brief: Lee's Pharmaceutical Reports Approval Of Intrarosa By NMPA